Drug Type Small molecule drug |
Synonyms AGX-A |
Target |
Action inhibitors |
Mechanism ID1 inhibitors(inhibitor of DNA binding 1, HLH protein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseEarly Phase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bile Duct Neoplasms | Phase 1 | United States | 09 Feb 2022 | |
Neoplasms | Preclinical | United States | 30 Apr 2025 | |
Dystrophy, Macular | Preclinical | United States | 09 Feb 2022 | |
Wet age-related macular degeneration | Discovery | United States | 30 Jan 2022 |